Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Asia Congress 2019

Proffered paper session - Gynaecological cancers

Patient-centred outcomes with maintenance olaparib in newly diagnosed patients with advanced ovarian cancer (OC) and a BRCA mutation in the phase III SOLO1 trial to support the clinical benefit of prolongation of progression-free survival (PFS)

Date

24 Nov 2019

Session

Proffered paper session - Gynaecological cancers

Topics

Tumour Site

Ovarian Cancer

Presenters

Michael Friedlander

Citation

Annals of Oncology (2019) 30 (suppl_9): ix77-ix90. 10.1093/annonc/mdz426

Authors

M.L. Friedlander1, K.N. Moore2, N. Colombo3, G. Scambia4, B. Kim5, A. Oaknin6, A. Lisyanskaya7, A. Floquet8, A. Leary9, G.S. Sonke10, C. Gourley11, S. Banerjee12, A. Oza13, A. González-Martín14, C. Aghajanian15, W. Bradley16, E. Lowe17, R. Hettle18, E. Flood17, P. Disilvestro19

Author affiliations

  • 1 -, University of New South Wales Clinical School, Prince of Wales Hospital, - - Randwick/AU
  • 2 -, Stephenson Cancer Center at the University of Oklahoma, - - Oklahoma City/US
  • 3 -, University of Milan-Bicocca and Istituto Europeo di Oncologia, - - Milan/IT
  • 4 -, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica, - - Roma/IT
  • 5 -, Samsung Medical Center, Sungkyunkwan University School of Medicine, - - Seoul/KR
  • 6 -, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona/ES
  • 7 -, St Petersburg City Oncology Dispensary, St Petersburg/RU
  • 8 -, Institut Bergonié, Comprehensive Cancer Centre, Bordeaux, and Groupe d’Investigateurs Nationaux pour l’Etude des Cancers Ovariens, 33076 - -/FR
  • 9 -, Gustave-Roussy Cancer Campus, Villejuif, and Groupe d’Investigateurs Nationaux pour l’Etude des Cancers Ovariens, -/FR
  • 10 -, The Netherlands Cancer Institute, Amsterdam/NL
  • 11 -, Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh/GB
  • 12 -, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London/GB
  • 13 -, Princess Margaret Cancer Centre, - - Toronto/CA
  • 14 -, Clínica Universidad de Navarra, Madrid/ES
  • 15 -, Memorial Sloan Kettering Cancer Center, New York/US
  • 16 -, Froedtert and the Medical College of Wisconsin, Milwaukee/US
  • 17 -, AstraZeneca, Gaithersburg/US
  • 18 -, AstraZeneca, Cambridge/GB
  • 19 -, Women & Infants Hospital, Providence/US

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.